Evaluation of the Intranasal Fentanyl Protocol in Pediatric Surgical Emergencies at Strasbourg University Hospital

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Emergency trauma departments receive thousands of patients each year whose main symptom is pain. In recent years, intranasal fentanyl (FIN) has entered the therapeutic arsenal to treat pain in the emergency department. Various studies have validated its effectiveness for musculoskeletal pain as well as its tolerance and safety of use. Since then, new protocols have been implemented including this treatment. In This study, the investigators propose to retrospectively study the quality of prescription of intranasal fentanyl in the treatment of pain in the emergency department and the quality of monitoring of this treatment in current practice.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 1
Maximum Age: 17
View:

• Child \< 18 years old

• Child treated in the pediatric emergency department of Strasbourg University Hospital

• Child who has benefited from intranasal fentanyl between 08/01/2022 and 09/31/2024.

• Child (and/or his/her parental authority) who has not expressed, after information, his/her (their) opposition to the reuse of his/her health data for the purposes of this research.

Locations
Other Locations
France
Service d'Urgences Médico-Chirurgicales Pédiatriques - CHU de Strasbourg - France
RECRUITING
Strasbourg
Contact Information
Primary
Dimitar TCHOMAKOV, MD
Dimitar.tchomakov@chru-strasbourg.fr
33 3 88 12 81 18
Time Frame
Start Date: 2024-10-28
Estimated Completion Date: 2026-04-28
Participants
Target number of participants: 500
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Strasbourg, France

This content was sourced from clinicaltrials.gov